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     Visual inspection may be the first 
noticeable sign that an infant maybe have 
pathologic jaundice but is not the most 
accurate method to determine elevated 
bilirubin levels.  Trying to estimate serum 
bilirubin by using clinical examination is not 
reliable and therefore not recommended 
(Dennery, Seidman, Stevenson, 2001).  
Jaundice is defined as the yellow-orange 
discoloration found in the sclera, skin, and 
other tissues of infants (Schwartz, 
Haberman, & Ruddy, 2011).  Jaundice is 
hard to observe in dark skin babies.  Even 
though jaundice may indicate an imbalance 
of production and elimination of bilirubin it 
does not imply any specific cause (Cohen, 
Wong, & Stevenson, 2010).  It is 
recommended that babies that appear to 
look jaundice or have risk factors should be 
evaluated using total serum bilirubin (TSB) 
or transcutaneous bilirubin (TcB).  
Performing both the universal TSB/TcB 
screening along with using the risk factor 
scoring system seems to be the most 
reliable method for identifying infants at 
high risk for hyperbilirubinemia.  Detection 
of those infants that are at high risk for 
increased bilirubin levels allows for earlier 
treatment options leading to improved 
clinical outcomes (Muchowski, 2014).   
     A mother who was O blood type and 
had a term baby with A+ blood type and 
was admitted to the NICU for elevated 
bilirubin levels of 10mg/dl.  The mother 
was wanting to understand why her baby 
had yellowed skin color.  It was explained 
to the mother that she makes antibodies 
against blood type A and blood type B and 
the antibodies are able to cross the 
placenta destroying the baby’s RBC’s.  
When RBC’s are destructed there is a rise 
in the bilirubin levels manifesting by 
causing a yellowish tint to the infants skin 
color (Rubarth, 2011).  In this particular 
study knowing the mother was O blood 
type  that meant there were three blood 
type possibilities for the father.  The 
below table shows the three genotype 
possibilities for the father that would 
result in the infant have an A+ blood type.  
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ABO incompatibility can happen between a mother and baby primarily 
when the mother has blood type O and the developing fetus has blood type 
A, B, or AB.  This happens because mothers with type O blood have anti-A 
and anti-B antibodies because the baby has A, B, or AB blood type.  These 
antibodies cross the placenta and go into the fetal circulation.  The 
antibodies then attach to the infant’s red blood cells (RBC’s) causing 
hemolysis of the RBC’s.  The attaching and attacking by the antibodies 
starts while the baby is still in utero.  Hemolysis of RBC’s cause an increase 
in bilirubin levels.  In order for hemolysis to occur the antibodies have to 
attach to the RBC’s (Rubarth, 2011).  
Pathophysiology 
     The primary reason that healthcare workers assess for 
hyperbilirubinemia is because of the chance of neurotoxic effects (Dennery, 
et al., 2001).  This can happen by the bilirubin crossing the blood-brain 
barrier and entering the brain tissue (Lauer & Spector, 2011).  When this 
happens it poses a risk of developing neurological dysfunction (Stevenson, 
Vreman, & Wong, 2011).  Kernicterus is the term used to describe the 
permanent development of bilirubin toxicity (Schwartz, et al., 2011).  
Bilirubin can only enter the brain if it is not bound to albumin or is 
unconjugated (Dennery, et al., 2001).  If the babies serum albumin level is 
low this causes the binding of bilirubin to be compromise leading to an 
increase chance of kernicterus (Dennery, et al., 2001).  Even though 
kernicterus is not seen very much anymore it is still important to continue 
to prevent it by being meticulous in assessing and treating elevated levels 
of bilirubin (Dennery, et al., 2001).  
Significance of Pathophysiology 
     Neonatal jaundice is a common 
condition present in infants after birth.  It is 
caused by elevated bilirubin in the blood.  
It can affect up to 84% of term infants and 
is one of the most common cause for 
hospital readmission for the neonatal 
department (Muchowski, 2014).  It typically 
appears within 24 hours of life and is 
normally present in otherwise healthy 
newborns.  Physiologic jaundice, also 
known as unconjugated bilirubin, is a 
normal process that happens in neonates 
because the hepatic system is not matured 
yet (Kirk, 2008).  Majority of the time 
physiologic jaundice resolves on its own.  
Pathological jaundice, also known as 
conjugated bilirubin, in newborns is due to 
other reasons other than the normal 
pathologic process the newborn hepatic 
system goes through.  It may be a result of 
endocrine or genetic disorders, which are 
considered to be rare (Kirk, 2008).  A more 
common cause is due to ABO 
incompatibility. For the purpose of this 
poster the focus is going to be on 
pathologic elevated bilirubin specifically 
related to ABO incompatibility between 
mother and baby.  
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     Nurses are the front line to caring for 
mothers and infants that might have 
conjugated elevated bilirubin.  Nurses play 
an important role in promoting follow-up, 
assessing infants for risk factors, assessing 
jaundice level using the TSB or TcB (Wells, 
Ahmed, & Musser, 2013).  Many hospitals 
do not allow nurses to independently 
check bilirubin levels without a physician 
order.  Therefore this can create a barrier 
to diagnosing hyperbilirubinemia.  If there 
was a system in place to allow the nurses 
to check the bilirubin levels of infants 
based on certain risk factors or clinical 
suspicion might help diagnose 
hyperbilirubinemia before it becomes life-
threatening.  Follow-up is important 
because infants are being discharged 
sooner making them not available to 
healthcare workers when the bilirubin 
levels peak.  Having a protocol in place for 
when infants are discharged may help to 
ensure follow-up bilirubin testing.  The 
parents must understand the potential 
risk with hyperbilirubinemia and that is 
where the nurse can play a strong role 
(Bhutani, Schwoebel, & Gennaro, 2006).  It 
is important that nurses stay up to date on 
completing ongoing education and passing 
required competencies in order to provide 
the best possible care to the patients.  
Nurses should be well educated about 
conjugated hyperbilirubinemia in order to 
properly educate the parents of the babies 
diagnosed with elevated bilirubin and 
answer any questions they might have.  
Implications to 
Nursing 
Conclusion 
     Even though jaundice can be a 
normal physiological process that 
newborns go through it is important to 
determine whether it has a pathologic 
component to it in order to properly 
monitor and treat it.  If not properly 
diagnosed and treated than the risk of 
developing long term neurological 
damage is increased.  It is important to 
be able to know what to look for and 
know the risks associated with 
hyperbilirubinemia no matter if 
working in an inpatient or outpatient 
setting.  Early evaluation of infants is 
important to help determine diagnosis 
of pathologic hyperbilirubinemia 
before the baby is discharged home.  
Once discharge it is important to have 
a follow-up appointment scheduled 
within two to three days after 
discharge so the infant can be 
professionally examined for jaundice 
(Dennery, et al., 2001).   
Additional Sources 
Genotypes of Parents Mother’s Blood Type 
(O) 
Mother’s Blood Type 
(O) 
Father’s Blood Type (A) O O 
A AO AO 
A AO AO 
Table 1. Three possible genotypes for the father in the case study (Rubarth, 2011) 
Figure 1. Infant with pathologic jaundice 
Signs & Symptoms 
Genotypes of Parents Mother’s Blood Type 
(O) 
Mother’s Blood Type 
(O) 
Father’s Blood Type (A) O O 
A AO AO 
O OO OO 
Genotypes of Parents Mother’s Blood Type 
(O) 
Mother’s Blood Type 
(O) 
Father’s Blood Type (AB) O O 
A AO AO 
B BO BO 
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